G9a inhibition induces autophagic cell death via AMPK/mTOR pathway in bladder transitional cell carcinoma

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Li, Feng ^a   Zeng, Jin ^a   Gao, Yang ^a   Guan, Zhenfeng ^a   Ma, Zhenkun ^a   Shi, Qi ^a   Du, Chong ^a   Jia, Jing ^a   Xu, Shan ^a   Wang, Xinyang ^a   Chang, Luke ^a   He, Dalin ^a   Guo, Peng ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLADENINE; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; COMPOUND C; ENZYME INHIBITOR; G9A PROTEIN; HISTONE METHYLTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; RHEB PROTEIN; UNCLASSIFIED DRUG; EHMT2 PROTEIN, HUMAN; HISTOCOMPATIBILITY ANTIGEN; HISTONE LYSINE METHYLTRANSFERASE; TARGET OF RAPAMYCIN KINASE;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; ASSAY; AUTOPHAGY; BLADDER TRANSITIONAL CELL CARCINOMA; BRDU INCORPORATION ASSAY; CANCER CELL LINE; CELL DEATH; CELL PROLIFERATION; CELL VACUOLE; COLONY FORMATION ASSAY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FLUORESCENCE ANALYSIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LC 3 TURNOVER ASSAY; MTT ASSAY; P62 TURNOVER ASSAY; T24 CELL LINE; TRANSITIONAL CELL CARCINOMA; TRANSMISSION ELECTRON MICROSCOPY; UMUC 3 CELL LINE; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BLADDER TUMOR; CELL CYCLE CHECKPOINT; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AMP-ACTIVATED PROTEIN KINASES; APOPTOSIS; AUTOPHAGY; CARCINOMA, TRANSITIONAL CELL; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME INHIBITORS; HISTOCOMPATIBILITY ANTIGENS; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; URINARY BLADDER NEOPLASMS; VACUOLES;

EID: 84946924390     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138390     Document Type: Article

References (50)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA: A Cancer Journal for Clinicians 2014; 64 (1):9-29.
2. Witjes JA, Comperat E, Cowan NC, De Santis M, Gakis G, Lebret T, et al. EAU guidelines on muscleinvasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol 2014; 65(4):778-92. doi: 10.1016/j.eururo.2013.11.046 PMID: 24373477
3. Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Comperat E, et al. EAU guidelines on nonmuscle- invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 2013; 64(4):639-53. doi: 10.1016/j.eururo.2013.06.003 PMID: 23827737
4. Sylvester RJ, van der Meijden AP, OosterlinckW, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49(3):466-5; discussion 475-7. PMID: 16442208
5. Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet 2009; 374(9685):239-49. doi:10. 1016/S0140-6736(09)60491-8 PMID: 19520422
6. Di Pierro GB, Gulia C, Cristini C, Fraietta G, Marini L, Grande P, et al. Bladder cancer: a simple model becomes complex. Curr Genomics 2012; 13(5):395-415. doi: 10.2174/138920212801619232 PMID: 23372425
7. Cho HS, Kelly JD, Hayami S, Toyokawa G, Takawa M, Yoshimatsu M, et al. Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. Neoplasia 2011; 13(8):676-84. PMID: 21847359
8. Tachibana M, Sugimoto K, Nozaki M, Ueda J, Ohta T, Ohki M, et al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev 2002; 16(14):1779-91. PMID: 12130538
9. Kim Y, Kim YS, Kim DE, Lee JS, Song JH, Kim HG, et al. BIX-01294 induces autophagy-associated cell death via EHMT2/G9a dysfunction and intracellular reactive oxygen species production. Autophagy 2013; 9(12):2126-39. doi: 10.4161/auto.26308 PMID: 24322755
10. Zhang J, He P, Xi Y, Geng M, Chen Y, Ding J. Down-regulation of G9a triggers DNA damage response and inhibits colorectal cancer cells proliferation. Oncotarget 2015; 6(5):2917-27. PMID: 25595900
11. Oh ST, Kim KB, Chae YC, Kang JY, Hahn Y, Seo SB. H3K9 histone methyltransferase G9a-mediated transcriptional activation of p21. FEBS Lett 2014; 588(5):685-91. doi: 10.1016/j.febslet.2014.01.039 PMID: 24492005
12. Li KC, Hua KT, Lin YS, Su CY, Ko JY, Hsiao M, et al. Inhibition of G9a induces DUSP4-dependent autophagic cell death in head and neck squamous cell carcinoma. Mol Cancer 2014; 13:172. doi:10. 1186/1476-4598-13-172 PMID: 25027955
13. Ren A, Qiu Y, Cui H, Fu G. Inhibition of H3K9 methyltransferase G9a induces autophagy and apoptosis in oral squamous cell carcinoma. Biochem Biophys Res Commun 2015.
14. Ding J, Li T, Wang X, Zhao E, Choi JH, Yang L, et al. The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation. Cell Metab 2013; 18(6):896-907. doi: 10.1016/j.cmet.2013.11.004 PMID: 24315373
15. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008; 451(7182):1069-75. doi: 10.1038/nature06639 PMID: 18305538
16. Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol 2010; 221 (1):3-12. doi: 10.1002/path.2697 PMID: 20225336
17. Green DR, Galluzzi L, Kroemer G. Cell biology. Metabolic control of cell death. Science 2014; 345 (6203):1250256. doi: 10.1126/science.1250256 PMID: 25237106
18. Navarro-Yepes J, Burns M, Anandhan A, Khalimonchuk O, Del RL, Quintanilla-Vega B, et al. Oxidative stress, redox signaling, and autophagy: cell death versus survival. Antioxid Redox Signal 2014; 21 (1):66-85. doi: 10.1089/ars.2014.5837 PMID: 24483238
19. Green DR, Levine B. To be or not to be? How selective autophagy and cell death govern cell fate. Cell 2014; 157(1):65-75. doi: 10.1016/j.cell.2014.02.049 PMID: 24679527
20. Cui J, Sun W, Hao X, Wei M, Su X, Zhang Y, et al. EHMT2 inhibitor BIX-01294 induces apoptosis through PMAIP1-USP9X-MCL1 axis in human bladder cancer cells. Cancer Cell Int 2015; 15(1):4. doi: 10.1186/s12935-014-0149-x PMID: 25685062
21. Kimura S, Noda T, Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 2007; 3(5):452-60. PMID: 17534139
22. Kou B, Gao Y, Du C, Shi Q, Xu S, Wang CQ, et al. miR-145 inhibits invasion of bladder cancer cells by targeting PAK1. Urol Oncol 2014; 32(6):846-54. doi: 10.1016/j.urolonc.2014.01.003 PMID: 24954107
23. Dyrskjot L, Kruhoffer M, Thykjaer T, Marcussen N, Jensen JL, Moller K, et al. Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res 2004; 64(11):4040-8. PMID: 15173019
24. Clarke PGH, Puyal J. Autophagic cell death exists. Autophagy 2014; 8(6):867-869.
25. Wirawan E, Lippens S, Vanden BT, Romagnoli A, Fimia GM, Piacentini M, et al. Beclin1: a role in membrane dynamics and beyond. Autophagy 2012; 8(1):6-17. doi: 10.4161/auto.8.1.16645 PMID: 22170155
26. Parmar N, Tamanoi F. Rheb G-Proteins and the Activation of mTORC1. Enzymes 2010; 27:39-56. PMID: 25429186
27. Shaw RJ. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiologica 2009; 196(1):65-80. doi: 10.1111/j.1748-1716.2009.01972.x PMID: 19245654
28. Kim SY. Cancer metabolism: strategic diversion from targeting cancer drivers to targeting cancer suppliers. Biomol Ther (Seoul) 2015; 23(2):99-109.
29. Chen S, Rehman SK, Zhang W, Wen A, Yao L, Zhang J. Autophagy is a therapeutic target in anticancer drug resistance. Biochim Biophys Acta 2010; 1806(2):220-9. doi: 10.1016/j.bbcan.2010.07.003 PMID: 20637264
30. Rah B, Ur RR, Nayak D, Yousuf SK, Mukherjee D, Kumar LD, et al. PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells. Autophagy 2015; 11(2):314-31. doi: 10.1080/15548627.2015.1017182 PMID: 25803782
31. Yuan Y, Tang AJ, Castoreno AB, Kuo SY, Wang Q, Kuballa P, et al. Gossypol and an HMT G9a inhibitor act in synergy to induce cell death in pancreatic cancer cells. Cell Death Dis 2013; 4:e690. doi:10. 1038/cddis.2013.191 PMID: 23807219
32. Ke XX, Zhang D, Zhu S, Xia Q, Xiang Z, Cui H. Inhibition of H3K9 methyltransferase G9a repressed cell proliferation and induced autophagy in neuroblastoma cells. PLoS One 2014; 9(9):e106962. doi: 10.1371/journal.pone.0106962 PMID: 25198515
33. Xiong Y, Yepuri G, Forbiteh M, Yu Y, Montani JP, Yang Z, et al. ARG2 impairs endothelial autophagy through regulation of MTOR and PRKAA/AMPK signaling in advanced atherosclerosis. Autophagy 2014; 10(12):2223-38. doi: 10.4161/15548627.2014.981789 PMID: 25484082
34. Li F, Ma Z, Guan Z, Chen Y, Wu K, Guo P, et al. Autophagy Induction by Silibinin Positively Contributes to Its Anti-Metastatic Capacity via AMPK/mTOR Pathway in Renal Cell Carcinoma. International Journal of Molecular Sciences 2015; 16(4):8415-8429. doi: 10.3390/ijms16048415 PMID: 25884331
35. Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell 2009; 20 (7):1981-91. doi: 10.1091/mbc.E08-12-1248 PMID: 19211835
36. Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008; 30(2):214-26. doi: 10.1016/j.molcel. 2008.03.003 PMID: 18439900
37. Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003; 115(5):577-90. PMID: 14651849
38. Shang L, Chen S, Du F, Li S, Zhao L, Wang X. Nutrient starvation elicits an acute autophagic response mediated by Ulk1 dephosphorylation and its subsequent dissociation from AMPK. Proc Natl Acad Sci U S A 2011; 108(12):4788-93. doi: 10.1073/pnas.1100844108 PMID: 21383122
39. Efeyan A, Sabatini DM. mTOR and cancer: many loops in one pathway. Curr Opin Cell Biol 2010; 22 (2):169-76. doi: 10.1016/j.ceb.2009.10.007 PMID: 19945836
40. Alers S, Loffler AS, Wesselborg S, Stork B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol 2012; 32(1):2-11. doi: 10.1128/MCB.06159-11 PMID: 22025673
41. Loffler AS, Alers S, Dieterle AM, Keppeler H, Franz-Wachtel M, Kundu M, et al. Ulk1-mediated phosphorylation of AMPK constitutes a negative regulatory feedback loop. Autophagy 2011; 7(7):696-706. PMID: 21460634
42. Suva ML, Riggi N, Bernstein BE. Epigenetic reprogramming in cancer. Science 2013; 339 (6127):1567-70. doi: 10.1126/science.1230184 PMID: 23539597
43. Sui X, Jin L, Huang X, Geng S, He C, Hu X. p53 signaling and autophagy in cancer: a revolutionary strategy could be developed for cancer treatment. Autophagy 2011; 7(6):565-71. PMID: 21099252
44. Lebrun-Julien F, Suter U. Combined HDAC1 and HDAC2 Depletion Promotes Retinal Ganglion Cell Survival After Injury Through Reduction of p53 Target Gene Expression. ASN Neuro 2015;7(3).
45. Arcaro A. Involvement of autophagy in the response of tumor cells to PtdIns3K inhibitors: therapeutic implications. Autophagy 2013; 9(4):607-8. doi: 10.4161/auto.23461 PMID: 23324613
46. Sui X, Zhu J, Zhou J, Wang X, Li D, Han W, et al. Epigenetic modifications as regulatory elements of autophagy in cancer. Cancer Lett 2015; 360(2):106-13. doi: 10.1016/j.canlet.2015.02.009 PMID: 25687886
47. Artal-Martinez DNA, Gomez TS, Zhang JS, Mann AO, Taoda Y, Gorman JA, et al. Epigenetic regulation of autophagy by the methyltransferase G9a. Mol Cell Biol 2013; 33(20):3983-93. doi: 10.1128/MCB. 00813-13 PMID: 23918802
48. Ruderman NB, Xu XJ, Nelson L, Cacicedo JM, Saha AK, Lan F, et al. AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab 2010; 298(4):E751-60. doi: 10.1152/ajpendo.00745. 2009 PMID: 20103737
49. Li X. SIRT1 and energy metabolism. Acta Biochim Biophys Sin (Shanghai) 2013; 45(1):51-60.
50. Shankar SR, Bahirvani AG, Rao VK, Bharathy N, Ow JR, Taneja R. G9a, a multipotent regulator of gene expression. Epigenetics 2013; 8(1):16-22. doi: 10.4161/epi.23331 PMID: 23257913